- Home
- NVNO vs APLT Comparison
NVNO vs APLT Comparison
Compare NVNO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- APLT
- Stock Information
- Founded
- NVNO 1987
- APLT 2016
- Country
- NVNO United States
- APLT United States
- Employees
- NVNO N/A
- APLT N/A
- Industry
- NVNO Medical/Dental Instruments
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- NVNO Health Care
- APLT Health Care
- Exchange
- NVNO Nasdaq
- APLT Nasdaq
- Market Cap
- NVNO 41.0M
- APLT 37.5M
- IPO Year
- NVNO N/A
- APLT 2019
- Fundamental
- Price
- NVNO $3.51
- APLT $0.36
- Analyst Decision
- NVNO
- APLT Buy
- Analyst Count
- NVNO 0
- APLT 7
- Target Price
- NVNO N/A
- APLT $6.10
- AVG Volume (30 Days)
- NVNO 80.1K
- APLT 2.7M
- Earning Date
- NVNO 07-30-2025
- APLT 05-13-2025
- Dividend Yield
- NVNO N/A
- APLT N/A
- EPS Growth
- NVNO N/A
- APLT N/A
- EPS
- NVNO N/A
- APLT N/A
- Revenue
- NVNO N/A
- APLT $265,000.00
- Revenue This Year
- NVNO N/A
- APLT $1,768.13
- Revenue Next Year
- NVNO $409.09
- APLT $332.85
- P/E Ratio
- NVNO N/A
- APLT N/A
- Revenue Growth
- NVNO N/A
- APLT N/A
- 52 Week Low
- NVNO $2.03
- APLT $0.30
- 52 Week High
- NVNO $6.48
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- NVNO 52.54
- APLT 42.18
- Support Level
- NVNO $3.26
- APLT $0.37
- Resistance Level
- NVNO $3.81
- APLT $0.40
- Average True Range (ATR)
- NVNO 0.26
- APLT 0.06
- MACD
- NVNO -0.04
- APLT -0.01
- Stochastic Oscillator
- NVNO 33.78
- APLT 3.72
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.